Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Cancer Research|November 2, 2021
Estrogen Receptor: A Paradigm for Targeted TherapySenthil Damodaran, Gabriel N HortobagyiCell Reports. Medicine|April 8, 2026
Antibody-drug conjugates in breast cancer: Progress and future directionsAlexandra Bili Newman, Senthil Damodaran, Funda Meric-BernstamJournal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Focal takotsubo cardiomyopathy with high-dose interleukin-2 therapy for malignant melanomaSenthil Damodaran, Ewa Mrozek, David Liebner, et al.The Breast Journal|July 23, 2020
Clinical implications of breast cancer tumor genomic testingSenthil Damodaran, Quinne C Sember, Banu K ArunCancer Treatment Reviews|May 27, 2025
Paving the path ForwARd: Advances and challenges in androgen receptor targeting in breast cancerNithya Sridhar, Toshiaki Iwase, Xuemei Xie, et al.Lancet Regional Health. Americas|May 13, 2026
Real-world study of treatment patterns and outcomes in patients with HR+ breast cancer after progression on CDK4/6 inhibitor therapyAkshara Singareeka Raghavendra, Wei Qiao, Yu Shen, et al.CA: a Cancer Journal for Clinicians|January 12, 2026
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancerAkshara Singareeka Raghavendra, Senthil Damodaran, Carlos H Barcenas, et al.JAMA Network Open|April 28, 2025
Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal CarcinomaAkshara S Raghavendra, Roland Bassett, Senthil Damodaran, et al.NPJ Breast Cancer|February 9, 2026
Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancerAkshara Singareeka Raghavendra, Diane D Liu, Sarah Pasyar, et al.Human Pathology|July 28, 2019
HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological featuresQingqing Ding, Hui Chen, Bora Lim, et al.Pageof 5